Why are lymphocytes disproportionately affected by mycophenolic acid's inhibition of IMPDH compared to most other body cells?
Choose an answer, then check it.
Clinical Pharmacology · Transplant Medications
Antimetabolites
On this page 6 sections
In 30 seconds
Antimetabolites are the antiproliferative pillar of transplant immunosuppression, blocking the DNA-building machinery lymphocytes need to multiply. Mycophenolate mofetil (and its active form, mycophenolic acid) has largely replaced azathioprine in solid-organ transplant because it is more selective for lymphocytes. Both drugs pair with a calcineurin inhibitor and a corticosteroid in typical triple-drug maintenance regimens, sparing higher doses of the more toxic calcineurin inhibitors. Their shared risks are bone marrow suppression and infection, but each carries distinct dangers requiring dedicated monitoring.
The college version
Mycophenolate: mechanism and role
Mycophenolate mofetil is a prodrug rapidly hydrolyzed to mycophenolic acid, its active moiety. Mycophenolic acid reversibly inhibits inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme in the de novo pathway that synthesizes guanosine nucleotides for DNA and RNA. Most body cells bypass this block using a salvage pathway that recycles preformed purine bases, so they keep dividing relatively unaffected. T and B lymphocytes, however, depend heavily on de novo synthesis and lack a robust salvage route, so they are disproportionately starved of the nucleotides clonal proliferation requires. This selectivity is why mycophenolate is favored over older antiproliferative agents: it dampens the lymphocyte response driving rejection while sparing much of the rest of the bone marrow and epithelium, relative to azathioprine.
Mycophenolate: adverse effects and interactions
The most common dose-limiting toxicity is gastrointestinal: diarrhea, nausea, and abdominal pain, which can prompt dose splitting or a formulation switch. Myelosuppression also occurs, particularly leukopenia and anemia, requiring periodic blood count monitoring. Because immune cells are suppressed, patients face increased infection risk, including cytomegalovirus reactivation, and rarely, progressive multifocal leukoencephalopathy, a serious demyelinating brain infection tied to JC virus reactivation under profound immunosuppression. Mycophenolate is teratogenic, causing recognizable fetal malformation and pregnancy loss, so it is dispensed under a formal risk management program requiring pregnancy testing and confirmed contraception for anyone who can become pregnant, before and throughout treatment. Absorption is reduced by antacids containing magnesium or aluminum, by oral iron, and by cholestyramine, which binds mycophenolic acid in the gut and interrupts its enterohepatic recirculation; proton pump inhibitors can also blunt absorption, so spacing or monitoring is often needed.
Azathioprine: mechanism and role
Azathioprine is a prodrug converted to 6-mercaptopurine, which is further metabolized into thioguanine nucleotides incorporated into DNA, disrupting purine synthesis and arresting rapidly dividing lymphocytes. It was once a mainstay of transplant regimens but is now used less often there, displaced by mycophenolate's better selectivity and tolerability. It remains valuable in autoimmune disease, where its slower onset and steroid-sparing effect are useful.
Azathioprine: pharmacogenomics and adverse effects
Before starting azathioprine, testing for thiopurine S-methyltransferase (TPMT) and NUDT15 activity is recommended, because reduced enzyme function slows inactivation of thiopurine metabolites, letting them accumulate to dangerous levels. Patients with low activity face severe, sometimes life-threatening myelosuppression at usual treatment intensities. A separate, critical interaction involves allopurinol and febuxostat: both inhibit xanthine oxidase, an enzyme that normally breaks down 6-mercaptopurine, so co-administration can cause profound, potentially fatal bone marrow suppression unless carefully managed. Azathioprine also causes dose-related myelosuppression independent of these interactions, hepatotoxicity requiring liver monitoring, and, with long-term use, increased skin cancer risk, making sun protection and regular dermatologic surveillance essential to chronic management.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine your immune cells are a factory that only builds new parts from raw materials shipped in fresh — no reusing old parts lying around. Most other cells have a recycling bin of spare parts, so they keep working fine even if the fresh shipment stops. Mycophenolate blocks that fresh shipment, so the immune factory slows way down while most other cells barely notice. Azathioprine works similarly but is clumsier, and can hit other factories too, especially if a person's body is slow at cleaning up its own leftover chemical waste, or if other medicines block that cleanup. Doctors use these medicines to keep a transplanted organ safe from immune attack, alongside other helper medicines, while watching closely for signs the slowdown went too far.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A transplant patient on mycophenolate mofetil reports persistent diarrhea and abdominal discomfort. What is the clinical significance of this, and what else should the care team monitor for?
Show answer
Dose-limiting GI toxicity
Diarrhea and abdominal pain are common, dose-limiting side effects of mycophenolate and may prompt dose adjustment; the team should also watch bloodwork for myelosuppression (low white cells or anemia) and watch for signs of infection, since the drug broadly suppresses the immune system.
A woman of reproductive age is being started on mycophenolate mofetil. What key precaution must be addressed before and during therapy, and why?
Show answer
Pregnancy precautions
Mycophenolate is teratogenic, so the patient needs pregnancy testing before starting and reliable contraception throughout treatment, managed under a formal risk program, because the drug can cause serious birth defects and pregnancy loss.
Quick check
3 questions here. Answers stay hidden until you check.
A patient starting azathioprine is also taking allopurinol for gout. What is the primary concern?
Choose an answer, then check it.
Which testing is recommended before initiating azathioprine therapy?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.